Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marie-Emilie Willemin"'
Autor:
Marie‐Emilie Willemin, Shun Xin Wang Lin, Loeckie De Zwart, Liviawati S. Wu, Xin Miao, Raluca Verona, Arnob Banerjee, Baolian Liu, Rachel Kobos, Ming Qi, Daniele Ouellet, Jenna D. Goldberg, Suzette Girgis
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 7, Pp 1117-1129 (2024)
Abstract Cytokine release syndrome (CRS) was associated with teclistamab treatment in the phase I/II MajesTEC‐1 study. Cytokines, especially interleukin (IL)‐6, are known suppressors of cytochrome P450 (CYP) enzymes' activity. A physiologically b
Externí odkaz:
https://doaj.org/article/0dd1551fb54644b2acd2b604cad8206a
Publikováno v:
Clinical Pharmacokinetics. 61:1115-1128
A physiologically based pharmacokinetic (PBPK) modeling approach for esketamine and its metabolite noresketamine after esketamine intranasal administration was developed to aid the prediction of drug-drug interactions (DDIs) during the clinical devel
Autor:
Thomas K van der Made, Jan Snoeys, Lieve Dillen, Ils Pijpers, Daniel Scotcher, Aleksandra Galetin, Sophie Jonkers, Mario Monshouwer, Amin Rostami-Hodjegan, Frank Jacobs, Annett Kunze, Kathleen Steemans, An Tuytelaars, Marie-Emilie Willemin
Publikováno v:
Willemin, M, Van Der Made, T K, Pijpers, I, Dillen, L, Kunze, A, Jonkers, S, Steemans, K, Tuytelaars, A, Jacobs, F, Monshouwer, M, Scotcher, D, Rostami-hodjegan, A, Galetin, A & Snoeys, J 2021, ' Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions ', Clinical Pharmacokinetics . https://doi.org/10.1007/s40262-021-01004-2
BackgroundEndogenous biomarkers are promising tools to assess transporter-mediated drug–drug interactions early in humans.MethodsWe evaluated on a common and validated in vitro system the selectivity of 4-pyridoxic acid (PDA), homovanillic acid (HV
Autor:
Marie-Emilie Willemin, Shun Xin Wang Lin, Loeckie De Zwart, Liviawati S. Wu, Xin Miao, Raluca Verona, Arnob Banerjee, Baolian Liu, Rachel Kobos, Ming Qi, Daniele Ouellet, Jenna D. Goldberg, Suzette Girgis
Publikováno v:
Blood. 140:7253-7254
Autor:
Marie-Emilie Willemin, Annie Lumen
Publikováno v:
Toxicology and Applied Pharmacology. 365:84-100
Current practices for evaluating the cumulative risk of thyroid-active chemical mixtures (perchlorate, thiocyanate, nitrate) focus on the inhibition of thyroidal iodide uptake via the sodium iodide symporter (NIS) as the mode of action for potency eq
Autor:
Marie-Emilie Willemin, Thomas K. Van Der Made, Ils Pijpers, Lieve Dillen, Annett Kunze, Sophie Jonkers, Kathleen Steemans, An Tuytelaars, Frank Jacobs, Mario Monshouwer, Daniel Scotcher, Amin Rostami-Hodjegan, Aleksandra Galetin, Jan Snoeys
Publikováno v:
Clinical Pharmacokinetics. 61:463-463
Autor:
Annie Lumen, Marie-Emilie Willemin
Publikováno v:
Critical Reviews in Toxicology. 47:543-569
Exposure of the population to thiocyanate is predominantly through the diet and cigarette smoke. Thiocyanate is a potential thyroid disruptor due to its capacity to inhibit the uptake of iodide by the thyroid. Thiocyanate also interacts with the enzy
Autor:
Marie-Emilie Willemin, Annie Lumen
Publikováno v:
Toxicology and applied pharmacology. 307
Thyroid homeostasis can be disturbed due to thiocyanate exposure from the diet or tobacco smoke. Thiocyanate inhibits both thyroidal uptake of iodide, via the sodium-iodide symporter (NIS), and thyroid hormone (TH) synthesis in the thyroid, via thyro
Autor:
Christian Moesch, Sophie Desmots, Florence Anna Zeman, Marie-Emilie Willemin, Céline Brochot, Eric Leclerc, Rozenn Le Grand, François Lestremau
Publikováno v:
Toxicology and Applied Pharmacology
Toxicology and Applied Pharmacology, Elsevier, 2016, 294, pp.65-77. ⟨10.1016/j.taap.2016.01.011⟩
Toxicology and Applied Pharmacology, Elsevier, 2016, 294, pp.65-77. ⟨10.1016/j.taap.2016.01.011⟩
International audience; Permethrin, a pyrethroid insecticide, is suspected to induce neuronal and hormonal disturbances in humans. The widespread exposure of the populations has been confirmed by the detection of the urinary metabolites of permethrin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a015a89e50c4bb58b68080cefd3d04b
https://hal-ineris.archives-ouvertes.fr/ineris-01862928/file/2016-001_post-print.pdf
https://hal-ineris.archives-ouvertes.fr/ineris-01862928/file/2016-001_post-print.pdf
Publikováno v:
Toxicology in Vitro
Toxicology in Vitro, Elsevier, 2015, 29 (4), pp.803-812. ⟨10.1016/j.tiv.2015.03.003⟩
Toxicology in Vitro, Elsevier, 2015, 29 (4), pp.803-812. ⟨10.1016/j.tiv.2015.03.003⟩
In vitro metabolism of permethrin, a pyrethroid insecticide, was assessed in primary human hepatocytes. In vitro kinetic experiments were performed to estimate the Michaelis–Menten parameters and the clearances or formation rates of the permethrin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911a686ab3a5e166199c0535d61c197d
https://hal-ineris.archives-ouvertes.fr/ineris-01855035
https://hal-ineris.archives-ouvertes.fr/ineris-01855035